Karim A

References (4)

Title : Identification of a Novel Scaffold for Inhibition of Dipeptidyl Peptidase-4 - Mishra_2019_J.Comput.Biol_26_1470
Author(s) : Mishra A , Cross M , Hofmann A , Coster MJ , Karim A , Sattar A
Ref : J Comput Biol , 26 :1470 , 2019
Abstract :
PubMedSearch : Mishra_2019_J.Comput.Biol_26_1470
PubMedID: 31390221

Title : Pharmacokinetics of alogliptin when administered with food, metformin, or cimetidine: a two-phase, crossover study in healthy subjects - Karim_2010_Int.J.Clin.Pharmacol.Ther_48_46
Author(s) : Karim A , Covington P , Christopher R , Davenport M , Fleck P , Li X , Wann E , Mekki Q
Ref : Int J Clinical Pharmacology & Therapeutics , 48 :46 , 2010
Abstract :
PubMedSearch : Karim_2010_Int.J.Clin.Pharmacol.Ther_48_46
PubMedID: 20040339

Title : Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects - Christopher_2008_Clin.Ther_30_513
Author(s) : Christopher R , Covington P , Davenport M , Fleck P , Mekki QA , Wann ER , Karim A
Ref : Clin Ther , 30 :513 , 2008
Abstract :
PubMedSearch : Christopher_2008_Clin.Ther_30_513
PubMedID: 18405789

Title : Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: a randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes - Covington_2008_Clin.Ther_30_499
Author(s) : Covington P , Christopher R , Davenport M , Fleck P , Mekki QA , Wann ER , Karim A
Ref : Clin Ther , 30 :499 , 2008
Abstract :
PubMedSearch : Covington_2008_Clin.Ther_30_499
PubMedID: 18405788